{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:05:05Z","timestamp":1794575105335,"version":"4.9.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>No validated questionnaires to assess the subjective aspects of premature ejaculation (PE) are currently in use. Clinical trials have generally only considered time, measured by ejaculatory latency, as an indicator of efficacy, but ejaculatory control, sexual satisfaction, and distress are important aspects of PE, which impact both the patient and his partner. The objective of this study was to develop and validate a new questionnaire to measure the overall experience of PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The questionnaire was developed using four stages: item pool development, initial psychometric analyses, patient interviews, and final psychometric analyses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>An item pool of 17 was generated and reduced to 10 items through the initial psychometric analyses. Patient interviews did not require addition of further items and resulted in only minor modifications to item wording for clarity. Final psychometric analyses of the 10-item measure confirmed a three-factor solution: sexual satisfaction, control, and distress. Reliability was good, both internal consistency and test\u2013retest reliability. Convergent validity using intravaginal ejaculatory latency time was excellent: control domain (0.75), sexual satisfaction domain (0.60), and distress domain (0.68). Known-groups validity was very good, all domain mean scores being statistically significantly worse in men with PE compared with the men reporting no PE problems.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The Index of Premature Ejaculation is a reliable and valid questionnaire for the assessment of control over ejaculation, satisfaction with sex life, and distress in men with PE. This tool has the potential to add value to interpretations of improvements in ejaculation latency resulting from new treatments of PE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2006.00239.x","type":"journal-article","created":{"date-parts":[[2006,3,16]],"date-time":"2006-03-16T18:00:53Z","timestamp":1142532053000},"page":"465-475","source":"Crossref","is-referenced-by-count":151,"title":["Development and Validation of a New Questionnaire to Assess Sexual Satisfaction, Control, and Distress Associated with Premature Ejaculation"],"prefix":"10.1093","volume":"3","author":[{"given":"Stanley","family":"Althof","sequence":"first","affiliation":[{"name":"Sex and Marital Therapy South Florida , West Palm Beach , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Rosen","sequence":"additional","affiliation":[{"name":"University of Medicine and Dentistry Department of Psychiatry , Piscataway , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Symonds","sequence":"additional","affiliation":[{"name":"Worldwide Outcomes Research Pfizer Ltd , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Mundayat","sequence":"additional","affiliation":[{"name":"Clinical Statistics Pfizer Ltd , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"May","sequence":"additional","affiliation":[{"name":"Clinical Research and Development Pfizer Ltd , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Abraham","sequence":"additional","affiliation":[{"name":"Worldwide Outcomes Research Pfizer Ltd , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"2024032600201248200_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01541933","article-title":"Incidence and prevalence of sexual dysfunctions: A critical review of the empirical literature","volume":"19","author":"Spector","year":"1990","journal-title":"Arch Sex Behav"},{"key":"2024032600201248200_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunctions in the US: Prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"key":"2024032600201248200_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijir.3901250","article-title":"Sexual problems among women and men aged 40\u201380 years: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors","volume":"17","author":"Laumann","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032600201248200_bib4","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/jech.53.3.144","article-title":"Association of sexual problems with social, psychological and physical problems in men and women: A cross-sectional population survey","volume":"53","author":"Dunn","year":"1999","journal-title":"J Epidemiol Community Health"},{"key":"2024032600201248200_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/00926230390224738","article-title":"How does premature ejaculation impact a man's life?","volume":"29","author":"Symonds","year":"2003","journal-title":"J Sex Marit Ther"},{"key":"2024032600201248200_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1192\/bjp.152.5.629","article-title":"Marital problems and sexual dysfunctions: How are they related?","volume":"152","author":"Rust","year":"1988","journal-title":"Br J Psychiatry"},{"issue":"2 suppl","key":"2024032600201248200_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1743-6109.2005.20371.x","article-title":"The burden of premature ejaculation: The patient's perspective","volume":"2","author":"Sotomayer","year":"2005","journal-title":"J Sex Med"},{"key":"2024032600201248200_bib8","article-title":"PE partner interview study","author":"Pfizer Ltd","year":"2005"},{"key":"2024032600201248200_bib9","article-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"2024032600201248200_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/13651509809115376","article-title":"An empirical operational study of DSM-IV diagnostic criteria for PE","volume":"2","author":"Waldinger","year":"1998","journal-title":"Int J Psychiatry Clin Prac"},{"key":"2024032600201248200_bib11","first-page":"26","article-title":"Treatment of premature ejaculation: Selecting outcomes to determine efficacy","volume":"10","author":"Rowland","year":"2003","journal-title":"Bull Int Soc Sex Impot Res"},{"key":"2024032600201248200_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1023417718557","article-title":"Premature or rapid ejaculation: Heterosexual couples\u2019 perceptions of men's ejaculatory behavior","volume":"32","author":"Byers","year":"2003","journal-title":"Arch Sex Behav"},{"key":"2024032600201248200_bib13","article-title":"Premature ejaculation: Guideline on the pharmacologic management of premature ejaculation","author":"American Urological Association","year":"2004"},{"key":"2024032600201248200_bib14","article-title":"The \u201cPEQUEST\u201d: A multidimensional instrument for the assessment of premature ejaculation","author":"Hartmann","year":"1996"},{"key":"2024032600201248200_bib15","first-page":"121","article-title":"Sexual function of premature ejaculation patients assayed with the Chinese Index of Premature Ejaculation","volume":"6","author":"Yuan","year":"2004","journal-title":"Asian J Androl"},{"key":"2024032600201248200_bib16","article-title":"Measuring health: A guide to rating scales and questionnaires","author":"McDowell","year":"1996"},{"issue":"4 suppl","key":"2024032600201248200_bib17","first-page":"S87","article-title":"Sexual quality of life questionnaire for use in men with erectile dysfunction and premature ejaculation","volume":"14","author":"Symonds","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600201248200_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/0470846283","article-title":"Quality of life: Assessment, analysis and interpretation","author":"Fayers","year":"2000"},{"key":"2024032600201248200_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function: A multidimensional scale for the assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"J Urol"},{"key":"2024032600201248200_bib20","article-title":"10th revision. World Health Organization","author":"International classification of diseases","year":"1989"},{"key":"2024032600201248200_bib21","article-title":"Second international consultation on sexual medicine: Sexual dysfunctions in men and women","author":"Lue","year":"2004"},{"key":"2024032600201248200_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"2024032600201248200_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/009286150303700105","article-title":"Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials","volume":"37","author":"Sloan","year":"2003","journal-title":"Drug Info J"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531345X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531345X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/3\/465\/47743485\/jsm_3_3_465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/3\/465\/47743485\/jsm_3_3_465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:13:51Z","timestamp":1711415631000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/3\/3\/465\/6883753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,5,1]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2006.00239.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,5]]},"published":{"date-parts":[[2006,5,1]]}}}